dowin pharmaceutical private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 14 September 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 3 bids — NUYOS HEALTHCARE PRIVATE LIMITED appeared in 2 of them.
DOWIN PHARMACEUTICAL PRIVATE LIMITED
DOWIN PHARMACEUTICAL PRIVATE LIMITED
Financial Details
Registered Office
FLAT NO. 201, I-WING, SUNIL MHATRE COMPLEX, KONGAONNA-MUMBAI-Maharashtra-421311-India
Industry Classification
Business Services
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TendersAi transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
2
Contract Value
₹46K
L1 Bids
0
Recent Win Rate
0.0%
Performance Analytics
Dowin Pharmaceutical Private Limited: Government Tender Performance Analysis
Dowin Pharmaceutical Private Limited is establishing its presence in the Indian government tender ecosystem, focusing primarily on the Ministry of Defence. As of March 2025, the company has participated in 2 tenders. While their win rate is currently at 0.0%, their technical qualification rate stands at an impressive 100.0%, showcasing strong compliance with tender requirements. This tender performance analysis examines their early-stage participation, technical qualification prowess, and emerging procurement strategy within the Indian pharmaceutical sector.
TenderAI's assessment of Dowin Pharmaceutical reveals a 'Critical' financial health score of 22.5/100, reflecting the need for strategic improvements in bid efficiency and win rates. Despite the low win rate, their focus on specialized government procurement processes, particularly within the Department of Defence and Department of Military Affairs, positions them for potential future growth.
Their strategic positioning requires careful evaluation of competitive threats and optimization of bidding strategies to enhance their market share within the Indian pharmaceutical sector. Key areas for improvement include selective bidding, pre-bid qualification processes, and enhancing proposal quality.
Financial Performance Analysis
Dowin Pharmaceutical is in the nascent stages of its government tender journey, with all tender activities concentrated in FY 2024-25. A detailed examination of their financial metrics reveals the following:
-
Yearly Trends: Currently, all financial activity is within FY 2024-25.
| Fiscal Year | Bid Count | Win Count | Qualification Rate | Win Rate | Total Contract Value |